Randomised Phase II Study of Neoadjuvant BIBW 2992 Versus Herceptin Versus Lapatinib in Her2 Positive Breast Cancer Patients.
Phase of Trial: Phase II
Latest Information Update: 16 Oct 2013
At a glance
- Drugs Afatinib; Lapatinib; Trastuzumab
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 21 Sep 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 23 Aug 2011 Planned End Date changed from 1 Jul 2011 to 1 Aug 2011 as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History